Risk grade updatedRisk gradeEvidence verified
18 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3.Business profile
Pharmarent Oy
Pharmarent Oy's registered office is Valkeakoski. It is a limited company. The company was established on 1993-01-07. It operates in the industry of rental and operating of own or leased non-residential real estate. In its latest retained statement for 2025-12-31, revenue was €265,491 and operating profit was €28,670.
Business ID 0917745-1ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 0917745-1
- Sector
- Rental and operating of own or leased non-residential real estate
- Municipality
- Valkeakoski
- Company form
- Limited company
- Registration date
- 1993-01-07
- Business ID registration date
- 1993-02-19
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Kauppatori 5, 37600, Valkeakoski
Postal address: Töyräskatu 14, 33240, Tampere
Phone: +358401535545Source observation
Website: https://pharmarent.fiSource observation
People and decision-makers
Seija KivimäkiYrittäjä
About Pharmarent Oy
Financial position and key figures for the company.
Pharmarent Oy's location municipality is Valkeakoski. It is a limited company. The company was established on 1993-01-07. It operates in the industry of rental and operating of own or leased non-residential real estate. In its latest retained statement for 2025-12-31, revenue was €265,491 and operating profit was €28,670. The latest retained financial statement for 2025-12-31 shows revenue of €265,491 and profit for the financial year of -€1,620. Based on the latest retained statement, revenue growth was -37.9%, operating margin was +10.7%, and equity ratio was +53.2%.
Auxiliary business names
Public alternate names materialized from source observations.
GoodMood Cafe
Extended business activity
A longer directory- or registry-backed activity description that complements the short registry industry label.
Yhtiön toimiala on kemikaliotuotteiden, rohdos- ja luontaistuotteiden sekä terveydenhoitotuotteiden maahantuonti ja -vienti, tukkumyynti sekä lääkkeiden maahantuonti ja -vienti sekä tukkumyynti. Lisäksi yhtiö voi harjoittaa kiinteistöjen, huoneistojen, kalusteiden, koneiden, kulkuneuvojen ja laitteiden vuokrausta ja kauppaa. Yhtiön toimialana on hallinnollis-taloudellisten sekä markkinointi- ja mainostoimistopalveluiden tuottaminen sekä alaan liittyvä koulutus ja konsultointi. Yhtiö voi myös ostaa ja myydä arvopapereita ja harjoittaa sijoitustoimintaa. Yhtiön toimialaan kuuluu edelleen työvoiman vuokraus, koulutus- ja ohjelmapalveluiden tuottaminen ja myynti. Yhtiön toimialaan kuuluu myös ravintola- ja majoitustoiminnan harjoittaminen. Yhtiö voi antaa lainaa ja vakuuksia osakkeenomistajilleen tai muille yhtiön läheisessä intressipiirissä oleville yhtiöille tai henkilöille.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2025-12-31
0
0
Enriched source observation
Derived indicators
Revenue growth-37.9%
Operating margin10.7%
Equity ratio53.2%
Revenue€265,491-€162,256 (-37.9%) vs previous periodPrevious: €427,747
Operating profit (loss)€28,670+€2,200 (+8.3%) vs previous periodPrevious: €26,469
Profit (loss) for the financial year-€1,620+€8,255 (+83.6%) vs previous periodPrevious: -€9,875
Assets€2,281,254-€148,648 (-6.1%) vs previous periodPrevious: €2,429,902
Balance-sheet contextLatest financial period
Profit before taxes-€1,620Previous: -€9,875
Employees0Previous: 4
Revenue trend5 periods
€1,226,525
2021-12-31
€998,971
2022-12-31
€426,662
2023-12-31
€427,747
2024-12-31
€265,491
2025-12-31
Operating profit (loss) trend5 periods
€173,088
2021-12-31
€247,792
2022-12-31
-€36,340
2023-12-31
€26,469
2024-12-31
€28,670
2025-12-31
Profit (loss) for the financial year trend5 periods
€108,889
2021-12-31
€168,195
2022-12-31
-€73,400
2023-12-31
-€9,875
2024-12-31
-€1,620
2025-12-31
Assets trend5 periods
€3,507,740
2021-12-31
€3,107,679
2022-12-31
€2,471,918
2023-12-31
€2,429,902
2024-12-31
€2,281,254
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.
Equity ratioGood
66/100 · Improving
Current ratioNot assessable
0/100 · Trend unavailable
Operating profit marginGood
77/100 · Improving
Ratio history
| Ratio | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|
| Equity ratio | 32.2 % | 41.8 % | 49.5 % | 50.0 % | 53.2 % |
| Current ratio | - | - | - | - | - |
| Operating profit margin | 14.1 % | 18.5 % | -8.4 % | 6.0 % | 10.7 % |
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID0917745-1
VAT IDFI09177451
EU IDFIFPRO.0917745-1
MunicipalityValkeakoski
Current registered entries
1993-01-07Registered in Patent and Registration Office (Trade Register)
1993-02-19Registered in Tax Administration (Tax Administration)
1994-06-01VAT-liable for business activity in Tax Administration (VAT Register)
1995-03-01Registered in Tax Administration (Prepayment Register)
1996-12-01VAT-obliged for the transfer of rights to use immovable property in Tax Administration (VAT Register)
Responsible people
Public role relationships materialized from source observations.
Seija KivimäkiYrittäjäSources: 1 · Confidence: 76%
Kivimäki Seija InkeriVarsinainen jäsenSources: 3 · Confidence: 78%
Kivimäki Juha EinariVarajäsenSources: 2 · Confidence: 78%
Penttilä Antti-JussiTilintarkastajaSources: 2 · Confidence: 78%
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
B3
MonitorPharmarent Oy
49/100
Medium
Strong financial evidenceFinancial data included
Financial development is mostly stable or mixed.
4 comparable periodsProfitabilityImproving · 2 consecutive periods
SolvencyStable
LiquidityNot enough history
Same industryDescriptive comparison – does not change the model score.
73 peersSolvency59%
Better than 59% of peers
Profitability53%
Close to the peer-group midpoint
Revenue growth7%
Below 93% of peers
Supporting factors
- Strong equity ratio
- Strong operating profitability
- Active registered status
Risk factors to note
- Negative profitability or net result
- Losses in the latest and previous available periods
- Sharp year-over-year revenue drop
B3
2026-09-18
open-risk-grade-v0.14
The grade can use open digital financial statement data together with registry signals.
A serious financial risk signal affects this grade. Review the profile financial indicators as well.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry risklow
77/100
Industry context is low based on normalized open statistical inputs.
Age and continuityVakiintunut
90/100
The company has about 33 years of registry continuity.
Registry and status signalsVakaa
83/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Registry timeline
Trade register notifications shown on a timeline.
20 register eventsLatest event: 2026-05-01
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
Pharmarent Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.